CH554884A - Verfahren zur herstellung neuer trisubstituierter oxazole bzw. thiazole. - Google Patents

Verfahren zur herstellung neuer trisubstituierter oxazole bzw. thiazole.

Info

Publication number
CH554884A
CH554884A CH1648872A CH1648872A CH554884A CH 554884 A CH554884 A CH 554884A CH 1648872 A CH1648872 A CH 1648872A CH 1648872 A CH1648872 A CH 1648872A CH 554884 A CH554884 A CH 554884A
Authority
CH
Switzerland
Prior art keywords
thiazole
production
oxazoles
new trisubstituted
new
Prior art date
Application number
CH1648872A
Other languages
German (de)
English (en)
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB51823/66A external-priority patent/GB1145884A/en
Priority claimed from GB5620366A external-priority patent/GB1206403A/en
Priority claimed from GB2626267A external-priority patent/GB1147626A/en
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of CH554884A publication Critical patent/CH554884A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/02—Holding devices, e.g. on the body
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CH1648872A 1966-11-18 1967-11-16 Verfahren zur herstellung neuer trisubstituierter oxazole bzw. thiazole. CH554884A (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB51823/66A GB1145884A (en) 1966-11-18 1966-11-18 Thiazole derivatives
GB5620366A GB1206403A (en) 1966-12-15 1966-12-15 Oxazoles
GB2507667 1967-05-31
GB2626267A GB1147626A (en) 1966-07-15 1967-06-07 Thiazole derivatives
GB2738267 1967-06-14
CH1606467A CH528531A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer heterocyclischer Verbindungen aromatischen Charakters

Publications (1)

Publication Number Publication Date
CH554884A true CH554884A (de) 1974-10-15

Family

ID=27516268

Family Applications (9)

Application Number Title Priority Date Filing Date
CH1648872A CH554884A (de) 1966-11-18 1967-11-16 Verfahren zur herstellung neuer trisubstituierter oxazole bzw. thiazole.
CH1716871A CH545308A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer trisubstituierter Oxazole
CH1485573A CH560203A5 (xx) 1966-11-18 1967-11-16
CH1717071A CH556351A (de) 1966-11-18 1967-11-16 Verfahren zur herstellung neuer trisubstituierter oxazole.
CH1717171A CH545310A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer trisubstituierter Oxazole
CH1606467A CH528531A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer heterocyclischer Verbindungen aromatischen Charakters
CH1716971A CH545309A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer trisubstituierter Oxazole
CH1717271A CH536311A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer trisubstituierter Oxagole
CH1717371A CH560205A5 (xx) 1966-11-18 1967-11-16

Family Applications After (8)

Application Number Title Priority Date Filing Date
CH1716871A CH545308A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer trisubstituierter Oxazole
CH1485573A CH560203A5 (xx) 1966-11-18 1967-11-16
CH1717071A CH556351A (de) 1966-11-18 1967-11-16 Verfahren zur herstellung neuer trisubstituierter oxazole.
CH1717171A CH545310A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer trisubstituierter Oxazole
CH1606467A CH528531A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer heterocyclischer Verbindungen aromatischen Charakters
CH1716971A CH545309A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer trisubstituierter Oxazole
CH1717271A CH536311A (de) 1966-11-18 1967-11-16 Verfahren zur Herstellung neuer trisubstituierter Oxagole
CH1717371A CH560205A5 (xx) 1966-11-18 1967-11-16

Country Status (12)

Country Link
JP (1) JPS4938267B1 (xx)
BE (1) BE706625A (xx)
CH (9) CH554884A (xx)
DE (2) DE1670005C2 (xx)
ES (1) ES347319A1 (xx)
FI (1) FI50416C (xx)
FR (2) FR1584222A (xx)
IL (1) IL28803A (xx)
LU (1) LU54891A1 (xx)
NL (1) NL157012B (xx)
PL (1) PL72562B1 (xx)
SE (2) SE369307B (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2618547A1 (de) * 1975-05-02 1976-11-18 Lilly Industries Ltd Oxazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2096994A1 (en) * 1970-07-24 1972-03-03 Roussel Uclaf 2-para-cyclopropyl phenyl-4-(halo)phenyl-5-thiazolyl - alkanoic acids -antiinflammatory analgesic, antipyretic agents
JPS5113375U (xx) * 1974-07-18 1976-01-30
JPS5182675A (xx) * 1975-01-17 1976-07-20 Tokyo Shibaura Electric Co
US4168315A (en) * 1977-09-28 1979-09-18 The Upjohn Company Dianisyl thiazole compound, compositions and method of antithrombotic treatment
US4697012A (en) * 1984-07-25 1987-09-29 Merck & Co., Inc. Morpholino pyridyl thiazole compound
IT1204751B (it) * 1986-01-03 1989-03-10 Therapicon Srl Derivati idrosolubili dell'acido 4,5 -difenil- 2 -ossazolpropionico,loro preparazione ed utilizzo in composizioni farmaceutiche
ES2245660T3 (es) * 1990-11-30 2006-01-16 Otsuka Pharmaceutical Co., Ltd. Derivados de azol y su utilizacion como inhibidores de los radicales superoxidos.
WO1996003392A1 (en) * 1994-07-27 1996-02-08 G.D. Searle & Co. Substituted thiazoles for the treatment of inflammation
MY128323A (en) 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130759C (xx) * 1965-10-07

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2618547A1 (de) * 1975-05-02 1976-11-18 Lilly Industries Ltd Oxazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel

Also Published As

Publication number Publication date
FI50416B (xx) 1975-12-01
NL6715532A (xx) 1968-05-20
CH545310A (de) 1973-12-15
IL28803A (en) 1974-05-16
CH528531A (de) 1972-09-30
DE1670005C2 (de) 1982-06-09
LU54891A1 (xx) 1968-02-08
DE1795822C2 (de) 1982-07-15
JPS4938267B1 (xx) 1974-10-16
SE369307B (xx) 1974-08-19
FI50416C (fi) 1976-03-10
CH560203A5 (xx) 1975-03-27
BE706625A (xx) 1968-05-16
FR1584222A (xx) 1969-12-19
SE422209B (sv) 1982-02-22
ES347319A1 (es) 1969-05-16
NL157012B (nl) 1978-06-15
CH536311A (de) 1973-04-30
CH545309A (de) 1973-12-15
FR8018M (xx) 1970-08-03
DE1670005A1 (de) 1970-08-06
PL72562B1 (en) 1974-08-30
CH560205A5 (xx) 1975-03-27
CH545308A (de) 1973-12-15
CH556351A (de) 1974-11-29

Similar Documents

Publication Publication Date Title
CH447173A (de) Verfahren zur Herstellung neuer Penicilline
CH554884A (de) Verfahren zur herstellung neuer trisubstituierter oxazole bzw. thiazole.
AT299463B (de) Verfahren zur Herstellung neuer Isoxazolderivate
CH474486A (de) Verfahren zur Herstellung neuer Diphenylharnstoffe
CH361280A (de) Verfahren zur Herstellung neuer Oxazole
CH478094A (de) Verfahren zur Herstellung neuer a-Aminosäuren
CH519488A (de) Verfahren zur Herstellung neuer 19-Nor-androstatriene
CH470345A (de) Verfahren zur Herstellung neuer Styryläthanolamine
AT269137B (de) Verfahren zur Herstellung neuer Oxazolidinderivate
AT262506B (de) Verfahren zur Herstellung neuer Penicilline
CH464204A (de) Verfahren zur Herstellung neuer Isoxazole
CH540280A (de) Verfahren zur Herstellung neuer Thiazole
CH525236A (de) Verfahren zur Herstellung neuer Penicilline
CH473807A (de) Verfahren zur Herstellung neuer 4-Hydroxy-chinoline
CH429715A (de) Verfahren zur Herstellung neuer 4-Halogen-androstene
AT242864B (de) Verfahren zur Herstellung neuer Acylamino-cephalosporansäuren
CH475282A (de) Verfahren zur Herstellung neuer Penicilline
CH442311A (de) Verfahren zur Herstellung neuer Penicilline
AT248694B (de) Verfahren zur Herstellung neuer Telomerisate
AT310163B (de) Verfahren zur Herstellung neuer Oxazol- bzw. Thiazol-Derivate
CH439308A (de) Verfahren zur Herstellung neuer Phthalazinium-Verbindungen
AT209343B (de) Verfahren zur Herstellung neuer 8 a-Phenyl-decahydrochinoline bzw. 7 a-Phenyl-octahydroindole
CH470414A (de) Verfahren zur Herstellung neuer Penicilline
AT271724B (de) Verfahren zur Herstellung neuer Penicilline
CH440296A (de) Verfahren zur Herstellung neuer 2-Amino-1,3,4-oxadiazolderivate

Legal Events

Date Code Title Description
PL Patent ceased